巨子生物(02367)早盘涨超6%,高见69.30港元,创上市以来新高。截至发稿,股价上涨6.78%,现报69.30港元,成交额3.09亿港元。
大摩此前指出,预计公司2024及2025财年的盈利增长,将分别为37%和23%,即将公布的全年业绩或较该行覆盖范围内的其他公司更强。花旗此前研报表示,经修订后,预计巨子生物2024年收入将同比增52%,净利润同比增40%,与管理层指引增长一致。同时预计,2025-2026年净利润将分别增27%/21%,因受惠于收入增长分别30%/26%。
责任编辑:卢昱君
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.